Cargando…
Monoamine oxidase A: An emerging therapeutic target in prostate cancer
Monoamine oxidase A (MAOA), a mitochondrial enzyme degrading biogenic and dietary amines, has been studied in the contexts of neuropsychiatry and neurological disorders for decades, but its importance in oncology, as best exemplified in prostate cancer (PC) to date, was only realized recently. PC is...
Autores principales: | Chen, Chia-Hui, Wu, Boyang Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968829/ https://www.ncbi.nlm.nih.gov/pubmed/36860320 http://dx.doi.org/10.3389/fonc.2023.1137050 |
Ejemplares similares
-
Monoamine Oxidase A Inhibits Lung Adenocarcinoma Cell Proliferation by Abrogating Aerobic Glycolysis
por: Huang, Yumin, et al.
Publicado: (2021) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015) -
Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
por: Meenu, Meenakshi, et al.
Publicado: (2020) -
High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
por: Chen, Lingxiao, et al.
Publicado: (2023) -
ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)